ChuD.Z.J., LangN.P., ThompsonC., OsteenP.K., WestbrookK.C.: Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors.Cancer, 63: 364–367, 1989.
2.
SugarbakerP.H., CunliffeW.J., BelliveauJ., De BruijnE.A., GravesT., MullinsR.E., SchlagP.: Rationale for integrating early postoperative intraperitoneal chemotherapy (EPIC) into the surgical treatment of gastrointestinal cancer.Semin Oncol, 16: 83–97, 1989.
3.
OlesonJ.R., CalderwoodS.K., CoughlinC.T., DewhirstM.W., GerweckL.E., GibbsF.A.Jr., KappsD.S.: Biological and clinical aspects of hyperthermia in cancer therapy.Am J Clin Oncol, 11: 368–380, 1988.
4.
SugarbakerP.H., GravesT., De BruijnE.A., CunliffeW.J., MullinsR.E., CullW.E., OlifL., SchlagP.: Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies.Cancer Res, 50: 5790–5794, 1990.
5.
SugarbakerP.H., JablonskiK.A.: Prognostic factors of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy.Ann Surg, 221: 124–132, 1995.
6.
BozzettiF., VagliniM., DeracoM.: Intraperitoneal hyperthermic chemotherapy in gastric cancer: rationale for a new approach.Tumori, 84: 483–488, 1998.
7.
JacquetP., StephensA.D., AverbachA., ChangD., EttinghauS.E., DaltonR.R., StevesM.A., SugarbakerP.H.: Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heat intraoperative intraperitoneal chemotherapy.Cancer, 77: 2622–2629, 1996.
8.
EsquivelJ., Vidal-JoveJ., SteveM.A., SugarbakerP.H.: Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapy.Surgery, 113: 631–636, 1993.
